The Every Woman Study in Low- and Middle-Income Countries: Identifying challenges and opportunities to improve survival and quality of life for women with ovarian cancer
- Conditions
- Health Condition 1: C569- Malignant neoplasm of unspecifiedovary
- Registration Number
- CTRI/2022/11/047417
- Lead Sponsor
- The World Ovarian Cancer Coalition and the International Gynecologic Cancer Society
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1)Diagnosed with any stage or type of Ovarian / fallopian tube or primary peritoneal cancer with the previous five years(or date of completing the survey)
2)Women have already been informed of their diagnosis of Ovarian cancer at a previous appointment and administrator is confident the woman understands what she has been told. If there is any doubt , the administrator must check with the clinician caring for the woman.
1)They are attending the hospital or clinic to receive their diagnosis of ovarian cancer.
2)They are deemed too unwell to be able to cope with the demands of filling in the survey or responding to questions.
3)They are identified as having mental health concerns, learning difficulties, or medical conditions such as dementia, delirium, or psychosis to the extent that they would be unable to cope with the demands of filling in the survey or responding to questions, or do not understand their diagnosis
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To provide: patient experience evidence at a national level and large regional level; a level of comparability between participating countries and the average for all, and by country income status.Timepoint: 1yr
- Secondary Outcome Measures
Name Time Method To provide a standardised survey and methodology that can be used beyond this iteration of the study in new settings, regardless of country income, or to measure progress.Timepoint: 1 yr